Results of three analytical approaches on long-term efficacy of etanercept for psoriasis in daily practice.

Autor: van Lümig PP, Driessen RJ, Kievit W, Boezeman JB, van de Kerkhof PC, de Jong EM

Publikováno v: Journal of the American Academy of Dermatology; Jan2013 Supplement, Vol. 68 Issue s1, p57-63, 7p

Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registry.

Autor: van Hal TW; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, the Netherlands.; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., van den Reek JMPA; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Wenink MH; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, the Netherlands., Otero ME; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Ossenkoppele PM; Department of Dermatology, ZiekenhuisGroep Twente, Almelo/Hengelo, the Netherlands., Njoo MD; Department of Dermatology, ZiekenhuisGroep Twente, Almelo/Hengelo, the Netherlands., Oostveen A; Department of Dermatology, Gelre Ziekenhuizen, Apeldoorn, the Netherlands., Peters B; Department of Dermatology, Ziekenhuis Rijnstate, Arnhem, the Netherlands., Tjioe M; Department of Dermatology/DermaTeam, Bravis Ziekenhuis, Bergen op Zoom, the Netherlands., Kop EN; Department of Dermatology, Bernhoven Ziekenhuis, Uden, the Netherlands., Körver JEM; Department of Dermatology, Amphia Ziekenhuis, Breda, the Netherlands., Dodemont SRP; Department of Dermatology, Catharina Ziekenhuis, Eindhoven, the Netherlands., Kleinpenning MM; Department of Dermatology, Canisius-Wilhelmina Ziekenhuis, Nijmegen, the Netherlands., Berends MAM; Department of Dermatology, Slingeland Ziekenhuis, Doetinchem, the Netherlands., Veldkamp WR; Department of Dermatology, Ziekenhuis Gelderse Vallei, Ede, the Netherlands., van Doorn MBA; Department of Dermatology, ErasmusMC, Rotterdam, the Netherlands., Mommers JM; Department of Dermatology, St. Anna Ziekenhuis, Geldrop, the Netherlands., Lindhout RJ; Department of Dermatology, Jeroen Bosch Ziekenhuis, 's Hertogenbosch, the Netherlands., Kuijpers ALA; Department of Dermatology, Maxima Medisch Centrum, Eindhoven, the Netherlands., van Lümig PP; Department of Dermatology, Maastricht UMC+, Maastricht, the Netherlands., de Jonge CEJ; Department of Dermatology, UMC Utrecht, Utrecht, the Netherlands., Tupker RA; Department of Dermatology, Sint Antoniusziekenhuis, Nieuwegein, the Netherlands., Hendricksen J; Department of Dermatology, Streekziekenhuis Koningin Beatrix, Winterswijk, the Netherlands., Keijsers RR; Department of Dermatology, Zuyderland Medisch Centrum, Sittard-Geleen, the Netherlands., van den Hoogen FHJ; Faculty of Medical Sciences, Radboud University, Nijmegen, the Netherlands., Vriezekolk JE; Department of Rheumatology, Sint Maartenskliniek, Nijmegen, the Netherlands.; Department of Research & Innovation, Sint Maartenskliniek, Nijmegen, the Netherlands., de Jong EMGJ; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Dermatology, ZiekenhuisGroep Twente, Almelo/Hengelo, the Netherlands.

Publikováno v: The Journal of dermatological treatment [J Dermatolog Treat] 2024 Dec; Vol. 35 (1), pp. 2304025. Date of Electronic Publication: 2024 Jan 23.

Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-term drug-survival study from the BioCAPTURE registry.

Autor: Zweegers J; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., van den Reek JM; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., van de Kerkhof PC; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., Otero ME; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., Kuijpers AL; Maxima Medisch Centrum, Eindhoven/Veldhoven, the Netherlands., Koetsier MI; Gelre Ziekenhuizen, Apeldoorn, the Netherlands., Arnold WP; Ziekenhuis Gelderse Vallei, Ede, the Netherlands., Berends MA; Slingeland Ziekenhuis, Doetinchem, the Netherlands., Weppner-Parren L; Jeroen Bosch Ziekenhuis, Den Bosch, the Netherlands., Ossenkoppele PM; Ziekenhuisgroep Twente, Almelo, Hengelo, the Netherlands., Njoo MD; Ziekenhuisgroep Twente, Almelo, Hengelo, the Netherlands., Mommers JM; St Anna Ziekenhuis, Geldrop, the Netherlands., van Lümig PP; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., Driessen RJ; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., Kievit W; Department of Epidemiology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands., de Jong EM; Department of Dermatology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands.; Radboud University, Nijmegen, the Netherlands.

Publikováno v: The British journal of dermatology [Br J Dermatol] 2016 Aug; Vol. 175 (2), pp. 340-7. Date of Electronic Publication: 2016 Jun 25.

An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factors.

Autor: van Lümig PP; Department of Dermatology, Radboud university medical center, Nijmegen, The Netherlands., Menting SP, van den Reek JM, Spuls PI, van Riel PL, van de Kerkhof PC, Fransen J, Kievit W, de Jong EM

Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2015 Apr; Vol. 29 (4), pp. 752-60. Date of Electronic Publication: 2014 Sep 17.

'Happy' drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network.

Autor: van den Reek JM; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands., Zweegers J, Kievit W, Otero ME, van Lümig PP, Driessen RJ, Ossenkoppele PM, Njoo MD, Mommers JM, Koetsier MI, Arnold WP, Sybrandy-Fleuren BA, Kuijpers AL, Andriessen MP, van de Kerkhof PC, Seyger MM, de Jong EM

Publikováno v: The British journal of dermatology [Br J Dermatol] 2014 Nov; Vol. 171 (5), pp. 1189-96. Date of Electronic Publication: 2014 Oct 03.